Skip to search.
 TSX Down 0.04% TSX Ventures Up 0.63%

Amgen Inc. (AMGN)

-NasdaqGS
151.78 Down 4.11(2.64%) Aug 31, 4:00PM EDT
|Pre-Market : 148.40 Down 3.38 (2.23%) 8:12AM EDT - Nasdaq Real Time Price
Add to Portfolio
Prev Close:155.89
Open:155.33
Bid:148.30 x 500
Ask:149.77 x 100
1y Target Est:186.40
Beta:0.720556
Earnings Date:Oct 26 - Oct 30 (Est.)
Day's Range:151.30 - 156.35
52wk Range:127.67 - 181.81
Volume:4,359,718
Avg Vol (3m):3,524,180
Market Cap:115.09B
P/E (ttm):20.11
EPS (ttm):7.55
Div & Yield:3.16 (1.91%)
Quotes delayed, except where indicated otherwise. Currency in USD.

Comparison

Symbol% ChgMkt Cap
AMGNDown 2.64%115.09B
JNJDown 1.25%260.24B

Key Statistics

Forward P/E (1 yr):14.16
P/S (ttm):5.69
Ex-Dividend Date:13-Aug-15

Analysts

Annual EPS Est (Dec-15) :9.75
Quarterly EPS Est (Sep-15) :2.36
Mean Recommendation*:2.4
PEG Ratio (5 yr expected):1.33

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Amgen Inc., a biotechnology company, discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses for the treatment of illness in the areas of oncology, hematology, inflammation, bone health, nephrology, cardiovascular,... View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback